End-of-day quote
Other stock markets
|
||
- INR | - |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
08/05 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Chart calendar Natco Pharma Ltd.
Upcoming events on Natco Pharma Ltd.
Past events on Natco Pharma Ltd.
22/04/2024 12:00 pm | Investor Meeting - HSBC Global |
06/03/2024 12:00 pm | Investor Meeting - ICICI Securities |
28/02/2024 09:00 am | Investec Promoter & Founder Conference |
15/02/2024 11:00 am | Q3 2024 Earnings Call |
14/02/2024 02:08 pm | Q3 2024 Earnings Release |
15/12/2023 11:30 am | Investor Meeting - Kotak PCG |
29/11/2023 09:00 am | Investor Meeting |
28/11/2023 09:00 am | Investor Meeting - Day 1 |
15/11/2023 11:00 am | Q2 2024 Earnings Call |
14/11/2023 02:14 pm | Q2 2024 Earnings Release |
29/09/2023 10:30 am | Annual General Meeting |
10/08/2023 11:00 am | Q1 2024 Earnings Call |
09/08/2023 02:50 pm | Q1 2024 Earnings Release |
30/05/2023 11:00 am | Q4 2023 Earnings Call |
29/05/2023 02:22 pm | Q4 2023 Earnings Release |
10/02/2023 11:00 am | Q3 2023 Earnings Call |
09/02/2023 01:57 pm | Q3 2023 Earnings Release |
11/11/2022 11:00 am | Interim 2023 Earnings Call |
10/11/2022 01:41 pm | Interim 2023 Earnings Release |
30/09/2022 10:30 am | Annual General Meeting |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 20 945 22 060 -5.05% | 19 150 19 446 -1.52% | 20 521 21 294 -3.63% | 19 448 19 848 -2.02% | 27 071 26 844 0.85% | 39 185 |
EBITDA Million INR | Released Forecast Spread | 7 948 9 009 -11.77% | 5 826 6 531 -10.79% | 6 062 6 289 -3.61% | 2 635 5 360 -50.84% | 9 356 9 761 -4.15% | 16 899 |
EBIT Million INR | Released Forecast Spread | 7 138 8 815 -19.03% | 4 828 5 211 -7.35% | 4 893 5 247 -6.75% | 1 209 4 105 -70.55% | 7 718 8 088 -4.57% | 15 221 |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 8 247 8 947 -7.83% | 5 687 6 043 -5.88% | 5 796 6 107 -5.09% | 2 022 5 124 -60.54% | 8 619 9 068 -4.96% | 16 001 |
Net income Million INR | Released Forecast Spread | 6 444 6 969 -7.54% | 4 608 4 832 -4.64% | 4 409 4 739 -6.95% | 1 700 3 978 -57.26% | 7 153 7 188 -0.49% | 13 212 |
EPS INR | Released Forecast Spread | 34,9 37,8 -7.75% | 25,3 28,1 -10.08% | 24,2 26,0 -7.15% | 9,32 21,9 -57.44% | 39,2 39,5 -0.77% | 73,2 |
Announcement Date | 27/05/19 | 17/06/20 | 17/06/21 | 30/05/22 | 29/05/23 | - |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 3 313 4 556 -27.29% | 4 103 4 479 -8.4% | 3 772 4 390 -14.08% | 5 605 4 620 21.31% | 5 968 5 662 5.4% | 8 846 8 159 8.42% | 4 321 6 309 -31.51% | 4 925 5 421 -9.14% | 8 979 8 321 7.91% | 11 405 11 402 0.02% | 10 790 | 5 742 | 9 922 |
EBITDA Million INR | Released Forecast Spread | 762 1 268 -39.91% | 1 098 1 179 -6.84% | 705 1 134 -37.82% | 1 018 1 145 -11.05% | -186 2 002 -109.29% | 3 953 3 662 7.93% | 953 2 034 -53.14% | 1 059 1 322 -19.91% | 3 391 3 606 -5.95% | 5 280 5 247 0.63% | 4 930 | 1 284 | 4 376 |
EBIT Million INR | Released Forecast Spread | 692 | 3 504 | |||||||||||
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 910 853 6.68% | 698 1 067 -34.58% | 910 1 144 -20.45% | -496 1 323 -137.49% | 3 858 2 889 33.54% | 814 833 -2.28% | 3 244 1 583 104.93% | 5 000 4 273 17.01% | 4 672 | 4 732 | |||
Net income Million INR | Released Forecast Spread | 530 1 027 -48.39% | 750 779 -3.69% | 651 775 -15.96% | 804 862 -6.69% | -505 1 368 -136.92% | 3 204 2 192 46.17% | 568 1 385 -59% | 623 942 -33.87% | 2 758 2 596 6.22% | 4 203 3 957 6.22% | 5 355 | 833 | 3 241 |
EPS INR | Released Forecast Spread | 4,11 4,35 -5.52% | 3,57 4,80 -25.63% | 4,40 4,60 -4.35% | -2,77 7,30 -137.95% | 17,6 12,4 41.53% | 3,11 5,10 -39.02% | 3,41 3,90 -12.56% | 15,1 6,80 122.21% | 23,3 19,0 22.42% | 21,4 | 3,68 | 15,0 | |
Announcement Date | 17/06/21 | 12/08/21 | 11/11/21 | 14/02/22 | 30/05/22 | 09/08/22 | 10/11/22 | 09/02/23 | 29/05/23 | 09/08/23 | - | - | - |
Past sector events for Natco Pharma Ltd.
17/05/2024 06:22 pm | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
17/05/2024 01:58 pm | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
15/05/2024 07:35 pm | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
15/05/2024 11:00 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
15/05/2024 05:10 pm | CRESCO LABS INC.: Q1 2024 Earnings Release |
15/05/2024 12:33 pm | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
15/05/2024 | EISAI CO., LTD.: Q4 2023 Earnings Release |
15/05/2024 03:13 am | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
14/05/2024 02:22 pm | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
14/05/2024 11:00 am | BAYER AG: Q1 2024 Earnings Release |
- Stock Market
- Equities
- NATCOPHARM Stock
- Stock
- Calendar Natco Pharma Ltd.